Lexicon Pharmaceuticals (LXRX) Other Working Capital Changes (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Other Working Capital Changes data on file, last reported at $319000.0 in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 126.3% year-over-year to $319000.0 in Q1 2026; TTM through Mar 2026 was $775000.0, a 147.11% increase from a year earlier, with the FY2025 full-year figure at -$757000.0, down 26.59% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $319000.0, up from -$190000.0 in the prior quarter.
• Over the last five years, Other Working Capital Changes for LXRX reached as high as $4.0 million in Q2 2023 and fell as low as -$4.0 million in Q3 2023.
• Historically, Other Working Capital Changes has averaged $71000.0 across 5 years, with a median of -$191000.0 in 2025.
• Across the five-year window, Other Working Capital Changes soared 400.0% in 2022 and tumbled 1438.93% in 2023, its largest moves.
• Year by year, Other Working Capital Changes stood at -$1.1 million in 2022, then jumped by 392.01% to $3.3 million in 2023, then slumped by 166.12% to -$2.2 million in 2024, then jumped by 91.26% to -$190000.0 in 2025, then soared by 267.89% to $319000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $319000.0 in Q1 2026, -$190000.0 in Q4 2025, and -$191000.0 in Q3 2025.